281 related articles for article (PubMed ID: 35048593)
1. [Research Progress in Immunosuppressive Tumor Microenvironment of Gastrointestinal Cancer].
Li YT; Tan XY; Huang LN; Ma LX; Fu L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):7-14. PubMed ID: 35048593
[TBL] [Abstract][Full Text] [Related]
2. Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning.
Ye Z; Zeng D; Zhou R; Shi M; Liao W
Front Immunol; 2022; 13():819807. PubMed ID: 35603201
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster.
Mishra AK; Singh SK; Dayanandan S; Banerjee S; Chakraborty S; Gopal AB; Samal S; Poirah I; Chakraborty D; Bhattacharyya A
Cytokine; 2022 Aug; 156():155917. PubMed ID: 35660715
[TBL] [Abstract][Full Text] [Related]
4. Targeting the immune milieu in gastrointestinal cancers.
Turkes F; Mencel J; Starling N
J Gastroenterol; 2020 Oct; 55(10):909-926. PubMed ID: 32748171
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
[TBL] [Abstract][Full Text] [Related]
6. Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
Xu Y; Xiong J; Sun X; Gao H
Acta Pharm Sin B; 2022 Dec; 12(12):4327-4347. PubMed ID: 36561994
[TBL] [Abstract][Full Text] [Related]
7. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
8. Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play.
Donlon NE; Power R; Hayes C; Davern M; Reynolds JV; Lysaght J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499003
[TBL] [Abstract][Full Text] [Related]
9. Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review.
Wang C; Yuan M; Gao Y; Hou R; Song D; Feng Y
Oncol Res Treat; 2023; 46(5):177-191. PubMed ID: 36948165
[TBL] [Abstract][Full Text] [Related]
10. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies.
Zhang Y; Xu J; Zhang N; Chen M; Wang H; Zhu D
Cancer Lett; 2019 Aug; 458():123-135. PubMed ID: 31121212
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in Gastrointestinal Malignancies.
Surana R; Pant S
Adv Exp Med Biol; 2021; 1342():259-272. PubMed ID: 34972968
[TBL] [Abstract][Full Text] [Related]
12. Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies.
Peng X; Zheng J; Liu T; Zhou Z; Song C; Geng Y; Wang Z; Huang Y
Curr Cancer Drug Targets; 2024; 24(3):288-307. PubMed ID: 37537777
[TBL] [Abstract][Full Text] [Related]
13. Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.
Abolarinwa BA; Ibrahim RB; Huang YH
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540435
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment.
Looi CK; Chung FF; Leong CO; Wong SF; Rosli R; Mai CW
J Exp Clin Cancer Res; 2019 Apr; 38(1):162. PubMed ID: 30987642
[TBL] [Abstract][Full Text] [Related]
15. Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment.
Sun B; Hyun H; Li LT; Wang AZ
Acta Pharmacol Sin; 2020 Jul; 41(7):970-985. PubMed ID: 32424240
[TBL] [Abstract][Full Text] [Related]
16. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.
Jin Z; Sun X; Wang Y; Zhou C; Yang H; Zhou S
Front Immunol; 2022; 13():1018903. PubMed ID: 36300110
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in Gastrointestinal Malignancies.
Mizrahi J; Pant S
Adv Exp Med Biol; 2020; 1244():93-106. PubMed ID: 32301012
[TBL] [Abstract][Full Text] [Related]
18. The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook.
Zhou Z; Hu Y; Wu Y; Qi Q; Wang J; Chen L; Wang F
Mol Immunol; 2022 Nov; 151():218-230. PubMed ID: 36179604
[TBL] [Abstract][Full Text] [Related]
19. Current status of immunotherapy in gastrointestinal malignancies.
Lorenzen S; Lordick F; Loosen SH; Tacke F; Trautwein C; Roderburg C; Ettrich TJ; Perkhofer L; Reinacher-Schick A; Stein A
Z Gastroenterol; 2020 Jun; 58(6):542-555. PubMed ID: 32018315
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
